First Trimester Biochemical Screening for Trisomy 21: The Role of Free Beta hCG, Alpha Fetoprotein and Pregnancy Associated Plasma Protein A
Open Access
- 1 September 1994
- journal article
- research article
- Published by SAGE Publications in Annals of Clinical Biochemistry: International Journal of Laboratory Medicine
- Vol. 31 (5) , 447-454
- https://doi.org/10.1177/000456329403100504
Abstract
The potential efficacy of screening for trisomy 21 in the first trimester, using maternal serum markers α fetoprotein, free β human chorionic gonadotropin, unconjugated oestriol and pregnancy associated plasma protein A, was studied in an unselected population of women between the seventh and fourteenth week of gestation. Using a combination of α fetoprotein and free β human chorionic gonadotropin, 53% of affected pregnancies could be identified at a false positive rate of 5%. Unconjugated oestriol and pregnancy associated plasma protein A levels were lower in cases of trisomy 21, but their inclusion with other markers did not significantly improve detection rate. Monitoring the same pregnancies also in the second trimester showed that screening in the first trimester identified the same cases as in the second. We conclude that first trimester screening using free β human chorionic gonadotropin and α fetoprotein, is a viable possibility and will lead to detection rates in excess of 50%. Prospective studies are needed to confirm these observations.Keywords
This publication has 42 references indexed in Scilit:
- Maternal serum free beta hCG screening: Results of studies including 480 cases of down syndromePrenatal Diagnosis, 1994
- Prospective study of prenatal screening for Down's syndrome with free beta human chorionic gonadotrophin.BMJ, 1993
- First‐trimester biochemical screening for fetal chromosome abnormalities and neural tube defectsPrenatal Diagnosis, 1993
- Serum PAPP‐A levels are depressed in women with fetal Down syndrome in early pregnancyPrenatal Diagnosis, 1993
- First‐trimester free beta (hCG) screening for Down syndromePrenatal Diagnosis, 1993
- Antenatal screening for Down's syndrome.BMJ, 1993
- First‐trimester maternal serum human chorionic gonadotrophin as a marker for fetal chromosomal disordersPrenatal Diagnosis, 1992
- Prenatal screening for chromosome abnormalities using maternal serum chorionic gonadotrophin, alpha‐fetoprotein, and agePrenatal Diagnosis, 1991
- First‐trimester maternal serum biochemical indicators in Down syndromePrenatal Diagnosis, 1990
- FIRST-TRIMESTER BIOCHEMICAL SCREENING FOR DOWN SYNDROMEThe Lancet, 1988